Prevent Delirium
Empowering Hospitals
with Technology, Support and Data-Driven Decision Making
Delirium
Delirium Leads To
6x Nursing home admissions
14x Risk of dementia
7.4m EUR Average annual cost per hospital
Average length of stay increased by 3 days
Identify Patients with PIPRA
PIPRA has created the richest database in the market on POD, which is used to train our algorithm. Our CE-certified software is designed to fit into the clinical pathway with a simple to use interface that runs in the background once integrated, delivering an immediate stratification of risk.
- Secure web solution
- High performance
- No device required
- CE-marked
- Pay-per-use
- No installation required
- Flexible integration (0-100%)
- Patient data protected
- Delirium prevention support bundle included
- Fully integrated into your IT landscape
PIPRA explained
Revolutionizing Patient Care
Better POD Prevention
PIPRA’s score-based risk assessment helps clinicians to better personalise their patient’s operative plan and to decrease the risk of developing POD.
- Lower Delirium incidence
- Reduced length of stay
- Reduced nursing hours
- Improved risk assessment
- Improved Coding
POD tackling Strategy & Transformation support
Through training, informative materials, and on-the-ground support, care staff gains practical guidance to effectively manage delirium. This enables them to enhance their skills, improve patient care and experience the benefits of streamlined workflows.
POD Performance Insights
Continuous data-backed insights and feedback into daily delirium practices empowers hospitals to swiftly adapt their delirium management plan. PIPRA's robust data analytics capabilities further enhance hospitals' ability to make informed, data-driven decisions, streamline operations and ultimately optimize their financial performance.
Collaborate with us
.svg)
.svg)
.svg)
Medically Approved in EU (CE-certified)
Medically approved & reimbursed in:
Switzerland
Austria
Finland
Ireland
Germany
Belgium
Sweden
Portugal
France
The Netherlands
Spain
Estonia
Testimonials
"There is a perception that elective surgeries have become extremely safe, thanks to advances in operative technique and anesthesia care. This view overlooks the fact that a substantial number of patients, in particular older ones, experience adverse cognitive outcomes after surgery. PIPRA has a game-changing solution which squarely addresses this need. It estimates delirium risk accurately and reliably, thanks to an AI algorithm trained on routinely collected clinical data. This is an extraordinarily valuable tool which will have a positive impact on choices made by patients undergoing surgery and their families, as well as surgeons, anesthesiologists, nurses, and other professionals who have a stake in the perioperative enterprise.”
Director Division of Informatics and Precision Medicine (Prec. Med.), Co-director Prec. Med. Center of Excellence in Neurocritical Care, Head Lab. of Computational Intensive Care Med., Department of Anesthesiology & Critical Care Med., Secondary appointments in Biomedical & Electrical & Computer Engineering
“As clinicians consider and discuss surgical risks for their patients, we should similarly consider the risk for post-operative delirium. The use of PIPRA can personalize this risk calculation and provide both patients and clinicians with actionable information, with the purpose of instituting a delirium mitigation plan for that specific individual."
John & Terry Levin Family Professor of Medicine
Professor of Psychiatry and, by courtesy, of Internal Medicine, Surgery,
Emergency Medicine & Law Chief, Division of Medical Psychiatry
“PIPRA proposes a new tool that allows rapid determination of an individual patients risk to develop postoperative delirium after an operation. This is a very exciting and important development which can improve current clinical practice. We will finally be able to not only target resource intensive non-pharmacological preventive interventions to those patients who benefit the most but we will also be able to design clinical trials regarding delirium based on risk groups."
"PIPRA is a huge advancement compared to the usual standard of care. The score that distinguishes between those at risk and those who are not is tremendously helpful."
“In case of surgery, we all expect to recover fully and fast. The reality is often different. PIPRA is applying cutting edge technology to make surgery for all of us safer. PIPRA is a great idea with a great team to make it happen."
“Patients who develop delirium while in hospital cause a disproportionately high additional workload for nurses. This quickly becomes a vicious cycle. The less time nurses have for a patient, the higher the likelihood that the patient will develop delirium. PIPRA identifies patients who are at risk and thereby enables nurses to initiate and control the relevantclinical care process in a timely and targeted manner. Early intervention through PIPRA can prevent delirium, and decrease workload and stress fornurses. This is an important contribution to healthcare providers, considering the current high volume of work and the problem of scarce personnel resources in the field of nursing."
Our Publications
An Individual Patient Data Meta-Analysis
JAMA Netw Open. 2023;6(10):e2337239. doi:10.1001/jamanetworkopen.2023.37239
Age and Ageing, Volume 52, Issue 6, June 2023, afad086, Published: 08 June 2023 https://doi.org/10.1093/ageing/afad086
Want to contact us?
PIPRA AG has developed a cutting-edge AI-based pre-operative risk assessment tool called PIPRA (short for Pre-Interventional Preventive Risk Assessment), to assess the risk of a patient developing POD. The test uses standard medical data, is web-or app-based, and takes less than two minutes to provide a score-based risk assessment. This risk assessment enables doctors, nurses and health services to better personalise their patient’s operative plan and to introduce key clinical interventions to reduce the patient’s risk of developing POD.